U.S. markets open in 8 hours 23 minutes
  • S&P Futures

    +7.50 (+0.18%)
  • Dow Futures

    +83.00 (+0.24%)
  • Nasdaq Futures

    +12.25 (+0.09%)
  • Russell 2000 Futures

    +4.60 (+0.20%)
  • Crude Oil

    +0.38 (+0.59%)
  • Gold

    +3.10 (+0.17%)
  • Silver

    +0.36 (+1.30%)

    -0.0009 (-0.07%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    -1.70 (-9.24%)

    +0.0044 (+0.32%)

    +0.2810 (+0.26%)

    +1,074.26 (+1.84%)
  • CMC Crypto 200

    +139.07 (+9.69%)
  • FTSE 100

    +53.54 (+0.76%)
  • Nikkei 225

    +163.94 (+0.56%)

Brachytherapy Market Size to Reach USD 548.8 Million in 2027, Increasing Application of Brachytherapy in Cancer Treatment and Growing Demand for Minimally Invasive Procedures are Key Factors Driving Industry Growth, says Emergen Research

Newsfile Corp.
·6 min read

Vancouver, British Columbia--(Newsfile Corp. - April 14, 2021) - The global brachytherapy market size is expected to reach USD 548.8 Million in 2027 at a CAGR of 4.1% during the forecast period, according to current analysis by Emergen Research. Steady market revenue growth can be attributed to increasing application of brachytherapy in treatment of various cancers such as prostate cancer, gynecological cancer, breast cancer, and skin cancer among others. Rising demand and preference for minimally invasive procedures and increasing awareness about the disease in emerging economies are other key factors expected to drive revenue growth of the market over the forecast period.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/183

Brachytherapy generally involves placement of radioactive material inside the body to shrink tumor cells and is also known as internal radiation. It is one of the radiation therapies extensively used to treat cancers. Brachytherapy enables doctors to use high total dose of radiation to treat small areas in a time-efficient manner. This ensures less radiation is delivered to other surrounding tissues and significantly reduces risk of radiation-induced second malignancies. This has boosted adoption of brachytherapy in cancer treatment and is expected to drive revenue growth of the market over the forecast period.

Technological advancements in brachytherapy such as development of novel and efficient radioactive sources, rapid progress in 3D imaging methods, remote after-loading systems, development of computerized treatment methods, and clinical trials for brachytherapy are key factors expected to drive revenue growth of the market going ahead. However, presence of alternative therapies such as intensity-modulated radiation therapy and 3 dimensional conformal radiotherapy are expected to hamper market growth to a certain extent over the forecast period.

Some Key Highlights from the Report:

  • Key companies operating in the market include Elekta AB, CR Bard Inc., Varian Medical Systems Inc., Eckert & Ziegler BEBIG SA, CIVCO Medical Solutions, iCAD Inc., Isoray Medical Inc., Sun Nuclear Corporation, Theragenics Corporation, and Huiheng Medical Inc., among others.

  • In April 2020, Elekta introduced a universal gynecological brachytherapy applicator, Geneva, which has been designed by deploying the outside-in technique of the company. This technique caters to the increasing need of front-line cancer therapists.

  • High-dose rate (HDR) brachytherapy segment is expected to register significant revenue growth over the forecast period. HDR can be widely used for personalized dose distribution to cater to specific needs of patients by treating tumors with high localized radiation doses with minimal exposure of healthy tissues to radiation. This is a key factor driving revenue growth of this segment.

  • Prostate cancer is expected to account for largest revenue share in the global market over the forecast period owing to increasing application of brachytherapy in treatment of prostate cancer in early stages.

  • Specialty clinics are equipped with advanced radiotherapy instrument and devices and skilled staff to assist in diagnosing cancer and deciding appropriate treatment approach. This is expected to contribute to revenue growth of specialty clinics over the forecast period.

  • Asia Pacific market revenue is expected to expand at a CAGR of 5.6% during the forecast period attributable to increasing incidence of cancer, rising availability of favorable health insurance policies, and improvements in reimbursement policies.

Check Our Prices@ https://www.emergenresearch.com/select-license/183

For the purpose of this report, Emergen Research has segmented the global brachytherapy market on the basis of type, application, end-use, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)

  • High Dose Rate (HDR) Brachytherapy

  • Low Dose Rate (LDR) Brachytherapy

  • Others

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Prostate Cancer

  • Gynecological Cancer

  • Breast Cancer

  • Skin Cancer

  • Others

End-Use Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals

  • Specialty Clinics

  • Others

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/brachytherapy-market

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • U.K.

    • France


    • Rest of Europe

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of APAC

  • Latin America

    • Brazil

    • Rest of LATAM

  • Middle East & Africa

    • Saudi Arabia

    • U.A.E.

    • Rest of MEA

Take a Look at our Related Reports:

Organs-on-Chips Market By Type (Liver-on-Chip, Multiple Organs-on-Chips, Kidney-on-Chip, Heart-on-Chip, Lung-on-Chip, Intestine-on-Chip), By Application (Drug Discovery, Physiological Model Development, Toxicology Research), By End-Use (Pharmaceutical Firms, Research Institutes, Personal Care Industry), and By Region Forecast to 2028

RNA Transcriptomics Market By Product (Reagents, Instruments, Software, Service), By Technology (Microarrays, Polymerase Chain Reaction, RNA Sequencing, RNA Interference), By Application (Clinical Diagnostics, Toxicogenomics, Drug Discovery, Comparative Transcriptomics), By End-Use (Hospitals, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations). and By Region

Slide Stainers Market By Product (Reagents, Consumables & Accessories, Equipment), By Technology (Hematoxylin and Eosin, Immunohistochemistry, In Situ Hybridization, Cytology, Microbiology, Hematology, Special Stains), By End-Use (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Other), and By Region Forecast to 2028

High-performance Liquid Chromatography (HPLC) Market By Product (Instruments, Accessories, Consumables), By Application (Clinical Research, Forensic, Diagnostics, Other), By End-Use (Pharma and Bio-pharmaceutical Companies, Contract Research Organizations, Academic Institutions and Others), and By Region Forecast to 2028

Flow Imaging Microscopy Market By Sample Type (Large Biomolecule, Small Biomolecules, Liquid & Viscous Samples, Microfibers and Nano fibers, Others), By Sample Dispersion (Wet Dispersion, Dry Dispersion), By End-Use (Biotechnology Companies, Pharmaceutical Companies, Water Testing Laboratories, Food & Beverage Companies, Research & Academia, Metal Manufacturing, Chemical & Petrochemical Industries), and By Region Forecast to 2028

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-brachytherapy-market

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/80405